News and Events

Jennifer N. Brudno, Lekha Mikkilineni and Stephanie L Goff

A conversation with CCR immunotherapy experts

June is Immunotherapy Awareness Month. We asked members of the Surgery Branch about their work with immunotherapy as they continue to make important advances in this growing field.

Vassiliki Saloura receives 2021 Conquer Cancer Foundation of ASCO Career Development Award

Vassiliki Saloura, M.D., Ph.D., Physician-Scientist Early Investigator in the Thoracic and GI Malignancies Branch, is a recipient of the 2021 Career Development Award from Conquer Cancer, the American Society of Clinical Oncology Foundation. This award provides research funding to clinical investigators who have received their initial faculty appointment as they work to establish an independent clinical cancer research program.

CCR fellow receives 2021 Conquer Cancer Foundation of ASCO Young Investigator Award

Nobuyuki Takahashi, M.D., an NIH Hematology Oncology fellow, is a recipient of the 2021 Young Investigator Award from Conquer Cancer, the American Society of Clinical Oncology Foundation. This award provides funding to promising investigators to encourage and promote quality research in clinical oncology. The purpose of this grant is to fund physicians during the transition from a fellowship program to a faculty appointment.

William Figg receives 2021 ACCP Distinguished Investigator Award

William Douglas Figg Sr., Pharm.D., Deputy Chief of the Genitourinary Malignancies Branch, received the 2021 American College of Clinical Pharmacology Distinguished Investigator Award. This award recognizes superior scientific expertise and accomplishments by a senior investigator, usually involving a distinct area of research in basic or clinical pharmacology for which the individual is internationally known.

AACR Annual Meeting - Session II

A number of CCR scientists will present their research at the AACR Annual Meeting. The virtual session II takes place May 17-21, 2021.

Schematic showing the transcription of DNA into RNA

Live-cell imaging reveals variability in RNA processing

Real-time imaging of messenger RNA synthesis from hundreds of human genes reveals surprising variability in the way cells’ splicing machinery processes these molecules.

Elaine S. Jaffe to receive 2022 Gold-Headed Cane Award from the American Society for Investigative Pathology

Elaine S. Jaffe, M.D., NIH Distinguished Investigator in the Laboratory of Pathology, has been selected to receive the 2022 American Society for Investigative Pathology Gold-Headed Cane Award. This award recognizes significant long-term contributions to the field of pathology, including meritorious research, outstanding teaching, general excellence in the discipline and demonstrated leadership in the field.

Steven A. Rosenberg named 2021 Dan David Prize laureate

Steven A. Rosenberg, M.D., Ph.D., Chief of the Surgery Branch, is a recipient of the internationally renowned Dan David Prize, which honors individuals and organizations for outstanding contributions that expand knowledge of the past, enrich society in the present and promise to improve the future. Rosenberg is recognized in the “future” category for his contributions to molecular medicine, including his landmark discoveries leading to the first cancer immunotherapies and for his ongoing efforts to develop immunotherapy for solid tumors. He is one of three “future” category prize recipients and will be honored May 9, 2021, during a virtual ceremony.

Brigitte C. Widemann selected as a 2021 Sammies finalist

Brigitte C. Widemann, M.D., Chief of the Pediatric Oncology Branch, has been selected as one of 29 Samuel J. Heyman Service to America Medal (Sammies) finalists. These finalists are outstanding federal employees who serve the public good and are addressing many of our country’s greatest challenges. Widemann is nominated in the Science and Environment category for her pioneering clinical studies that led to Food and Drug Administration approval of selumetinib as the first treatment for children with neurofibromatosis type 1 who have symptomatic, inoperable plexiform neurofibromas.

Clinical trial evaluates COVID-19 vaccine in adults in treatment for cancer

Adults with hematologic malignancies or solid tumors may be eligible to participate in a new clinical trial at the NIH Clinical Center. Elad Sharon, M.D., M.P.H., Senior Investigator at the National Cancer Institute, is leading a study to assess the effects of the Moderna COVID-19 vaccine (mRNA-1273) in adults undergoing treatment for various types of cancer.

Breadcrumb